Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
April 10, 2019	8-K	Report of unscheduled material events or corporate event	0001193125-19-102254.pdf 0001193125-19-102254.rtf 0001193125-19-102254.xls View HTML
March 26, 2019	10-K	Annual report which provides a comprehensive overview of the company for the past year	0001564590-19-009340.pdf 0001564590-19-009340.rtf 0001564590-19-009340.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
March 19, 2019	NT 10-K	Notification that form 10-K will be submitted late	0001193125-19-078796.pdf 0001193125-19-078796.rtf 0001193125-19-078796.xls View HTML
March 19, 2019	CT ORDER	CT ORDER	9999999997-19-001395.pdf 9999999997-19-001395.rtf View HTML
March 18, 2019	8-K	Report of unscheduled material events or corporate event	0001193125-19-078247.pdf 0001193125-19-078247.rtf 0001193125-19-078247.xls View HTML
March 5, 2019	4	Statement of changes in beneficial ownership of securities	0001562180-19-001674.pdf 0001562180-19-001674.rtf View HTML
March 5, 2019	4	Statement of changes in beneficial ownership of securities	0001562180-19-001676.pdf 0001562180-19-001676.rtf View HTML
March 5, 2019	4	Statement of changes in beneficial ownership of securities	0001562180-19-001679.pdf 0001562180-19-001679.rtf View HTML
March 5, 2019	4	Statement of changes in beneficial ownership of securities	0001562180-19-001680.pdf 0001562180-19-001680.rtf View HTML
March 5, 2019	4	Statement of changes in beneficial ownership of securities	0001562180-19-001677.pdf 0001562180-19-001677.rtf View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax